It will be interesting to further determine whether vSMC recruitment and the KLF2-CXCL12/CXCR4-PDGFB pathway we have identified are involved in a causative way in lesion formation, or only secondarily affected as a result and/or part of developing CCM lesion pathology. The gene discussed is KLF2; the disease is cerebral cavernous malformation.